GAGA Share Market News

[hfe_template id='11223'] [ad_1] Pharmaceutical stocks are set to be in the spotlight on Monday, May 12, after U.S. President Donald Trump announced plans to slash prescription drug prices by 30% to 80% ‘almost immediately’, via his social media post on his “Truth Social” account on X. “I am pleased to announce that Tomorrow morning, in the White House, at 9:00 A.M., I will be signing one of the most consequential Executive Orders in our Country’s history. Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%,” Trump said in his X post. Link: https://x.com/TrumpDailyPosts/status/1921697332820578362 Trump made the announcement stating that the U.S. would pay the same price as the nation with the lowest pharmaceutical prices globally. “I will be instituting a MOST FAVORED NATION’S POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World. Our Country will finally be treat...

[hfe_template id='11223'] [ad_1] Indian pharmaceutical stocks fell up to 3% on the BSE on Thursday amid fears of tariffs by US President Donald Trump, with a fresh setback from the announcements in the auto sector having a rub-off impact. Shares of Aurobindo Pharmaceuticals fell 2% to their day’s low of Rs 1,132.75 while those of Ipca Laboratories went down by 2.7% to Rs 1,403.95. Sun Pharmaceuticals and Dr Reddy’s Laboratories shares tumbled 1.7% each and Ajanta Pharma shares slid by 2.5%. Meanwhile, the shares of Zydus Lifesciences, Alkem Laboratories, Lupin, and Natco Pharma were trading lower between 1% and 1.5% around 10:20 am. Speaking to reporters at the White House, Trump, in a previous speech, said the United States would need all those products if there were problems including wars. "We've been ripped off by every country," Trump said as he presided over a meeting of his Cabinet. Live Events Commerce Secretary Howard Lutnick, during the same meeti...

[hfe_template id='11223'] [ad_1] Pharma sector is expected to end as the top performer of 2024, closely followed by realty while the third spot could be occupied by consumer durables. Eight other sectors have delivered double-digit returns, outperforming the BSE Sensex on the year-to-date basis while energy, FMCG, banking and manufacturing have turned out to be market laggards.The BSE Healthcare’s 2024 returns as on December 23, Monday stood at 39% with 9 stocks delivering multibagger returns between 207% and 100% viz. Wockhardt, Indraprastha Medical Corporation, Neuland Laboratories, Vimta Labs, Shilpa Medicare, Orchid Pharma, Supriya Lifescience, Windlas Biotech and Solara Active Pharma. BSE Realty’s 35% returns are on the back of solid performances by stocks like Anant Raj, Sobha, Oberoi Realty, Prestige Estates and Godrej Properties which have given returns between 178% and 44%. Consumer durables, consumer discretionary, capital goods, power, information technolog...